Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT01614795

First received: June 6, 2012

Last updated: June 16, 2014

Last verified: June 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2013 (Final data collection date for primary outcome measure)